Furthermore, genome‐wide association studies (GWAS) have linked CDKN2A to many age‐related pathologies, including susceptibility to frailty and increased risk of coronary artery disease, myocardial infarction, type 2 diabetes, and Alzheimer's disease (Jeck et al., 2012). Here, CDKN2A is linked to Alzheimer disease.